Katharine Yao to Neoadjuvant Therapy
This is a "connection" page, showing publications Katharine Yao has written about Neoadjuvant Therapy.
Connection Strength
2.693
-
Are we Overtreating Hormone Receptor Positive Breast Cancer with Neoadjuvant Chemotherapy? Role of OncotypeDx® for Hormone Receptor Positive Patients Undergoing Neoadjuvant Chemotherapy. Ann Surg Oncol. 2019 Oct; 26(10):3232-3239.
Score: 0.534
-
Author's response. Breast J. 2018 11; 24(6):1143.
Score: 0.498
-
The Shifting Paradigm for Breast Cancer Surgery in Patients Undergoing Neoadjuvant Chemotherapy. Ann Surg Oncol. 2018 Jan; 25(1):164-172.
Score: 0.475
-
The Impact of Facility Volume on Rates of Pathologic Complete Response to Neoadjuvant Chemotherapy Used in Breast Cancer. Ann Surg Oncol. 2017 Oct; 24(11):3157-3166.
Score: 0.463
-
Are the ACOSOG Z0011 Trial Findings Being Applied to Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy? Breast J. 2017 Sep; 23(5):554-562.
Score: 0.453
-
ASO Author Reflections: Bilateral Mastectomy After Neoadjuvant Therapy: An Ever-Increasing Trend? Ann Surg Oncol. 2018 12; 25(Suppl 3):650-651.
Score: 0.127
-
Post-mastectomy radiation therapy and overall survival after neoadjuvant chemotherapy. J Surg Oncol. 2017 May; 115(6):668-676.
Score: 0.112
-
A Predictive Model for Axillary Node Pathologic Complete Response after Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg Oncol. 2018 May; 25(5):1304-1311.
Score: 0.030